The projected fair value for Ibotta is US$39.53 based on 2 Stage Free Cash Flow to Equity. Ibotta's US$23.62 share price signals that it might be 40% undervalued. Ou ...

ARK’s ARKK ETF also added 165,024 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) to its portfolio, valued at $9,706,711. The ...

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...

Below is a weekly earnings calendar of the most important upcoming quarterly reports scheduled to be released by publicly ...